Loading
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Dec 2025 for Immix Biopharma, Inc., €4,279.
Filing timeline
BuySaleIlya M. Rachman
Insider track record
Disclosed buys
10
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+44.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Ilya M. Rachman: trading record in brief
Ilya M. Rachman (chief executive) discloses dealings in Immix Biopharma, Inc. to SEC (Form 4). In total, 11 filings cover trades dated from 20 December 2021 to 10 December 2025.
Every open-market trade on record is a purchase: 10 purchases worth €49k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. 2025 to date brings 3 purchases and no sales.
In size, the median ticket on the buying side is €4,317. Of 10 purchases, 9 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 10 December 2025, reports an open-market purchase of €4,279 in Immix Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ilya M. Rachman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
746 shares@ US$6.679.0% of flowCommon StockSEC:0001493152-25-027109:0
Canonical exit: 10 Mar 2026 (T+90)
2,500 shares@ US$2.029.9% of flowCommon StockSEC:0001493152-25-013919:0
Canonical exit: 16 Dec 2025 (T+90)
2,178 shares@ US$2.29511.2% of flowCommon StockSEC:0001641172-25-015756:0
Canonical exit: 16 Sept 2025 (T+90)
2,600 shares@ US$2.1311.1% of flowCommon StockSEC:0001493152-24-023287:0
Canonical exit: 5 Sept 2024 (T+90)
3,300 shares@ US$1.809112.0% of flowCommon StockSEC:0001493152-24-022653:0
Canonical exit: 2 Sept 2024 (T+90)
218,359 sharesCommon StockSEC:0001493152-24-020778:0
4,300 shares@ US$2.246519.5% of flowCommon StockSEC:0001493152-24-019366:0
Canonical exit: 12 Aug 2024 (T+90)
4,050 shares@ US$1.0198.7% of flowCommon StockSEC:0001493152-22-032557:0
Canonical exit: 12 Feb 2023 (T+90)
2,500 shares@ US$5.0023.4% of flowCommon StockSEC:0001493152-21-032038:0
Canonical exit: 20 Mar 2022 (T+90)
9 of 9 declarations
